Patent Yard Sign in
Expired Canadian patentCanada

Agent for improving reduced functions of organs caused by inhibited blood circulation

CA 1314210 C · Owner: Kumano, Kazuo · Inventors: Nakamura, Kunie; Kumano, Kazuo; Kakimoto, Norihiro

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides (1)an agent for improving the reduced functions of organs caused by inhibited blood circulation charac-, terized by containing, as an effective component an organogermanium, compound represented by the formula (I) (I), wherein R1 to R3 are each a hydrogen atom a lower alkyl group such as, methyl, ethyl or the like which may be the same or different or a sub-, stituted or unsubstituted phenyl group and X is a hydroxyl group, an O-, lower alkyl group an amino group or O-Y+(Y is a metal such as sodium potassium or the like, or a basic group-containing compound such as lysozyme, basic amino acid or the like) and (2)a method for improving, the reduced functions of …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted March 9, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 9, 2010.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 20, 1988
GrantedMarch 9, 1993
Term endedMarch 9, 2010
Patent numberCA 1314210 C
Classification (IPC)A61K31/28 +1 more

Timeline

Timeline From CIPO dates

19891992199519982001200420072010Application filedOct 20, 1988Patent grantedMarch 9, 1993Term endedMarch 9, 2010

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.